rs2076584

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_018993.4(RIN2):​c.1818C>T​(p.His606His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.328 in 1,596,974 control chromosomes in the GnomAD database, including 92,739 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 10187 hom., cov: 33)
Exomes 𝑓: 0.33 ( 82552 hom. )

Consequence

RIN2
NM_018993.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.255

Publications

21 publications found
Variant links:
Genes affected
RIN2 (HGNC:18750): (Ras and Rab interactor 2) The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]
RIN2 Gene-Disease associations (from GenCC):
  • RIN2 syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 20-19990061-C-T is Benign according to our data. Variant chr20-19990061-C-T is described in ClinVar as Benign. ClinVar VariationId is 257654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.255 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.693 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIN2NM_018993.4 linkc.1818C>T p.His606His synonymous_variant Exon 10 of 13 ENST00000255006.12 NP_061866.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIN2ENST00000255006.12 linkc.1818C>T p.His606His synonymous_variant Exon 10 of 13 2 NM_018993.4 ENSP00000255006.7
RIN2ENST00000440354.2 linkc.519C>T p.His173His synonymous_variant Exon 5 of 8 1 ENSP00000391239.2
RIN2ENST00000484638.1 linkn.1662C>T non_coding_transcript_exon_variant Exon 6 of 9 1
RIN2ENST00000648440.1 linkc.1818C>T p.His606His synonymous_variant Exon 9 of 12 ENSP00000498085.1

Frequencies

GnomAD3 genomes
AF:
0.354
AC:
53782
AN:
152008
Hom.:
10172
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.387
Gnomad AMI
AF:
0.284
Gnomad AMR
AF:
0.471
Gnomad ASJ
AF:
0.330
Gnomad EAS
AF:
0.712
Gnomad SAS
AF:
0.253
Gnomad FIN
AF:
0.231
Gnomad MID
AF:
0.274
Gnomad NFE
AF:
0.308
Gnomad OTH
AF:
0.376
GnomAD2 exomes
AF:
0.368
AC:
82119
AN:
223160
AF XY:
0.353
show subpopulations
Gnomad AFR exome
AF:
0.384
Gnomad AMR exome
AF:
0.597
Gnomad ASJ exome
AF:
0.337
Gnomad EAS exome
AF:
0.710
Gnomad FIN exome
AF:
0.231
Gnomad NFE exome
AF:
0.304
Gnomad OTH exome
AF:
0.340
GnomAD4 exome
AF:
0.325
AC:
469719
AN:
1444848
Hom.:
82552
Cov.:
34
AF XY:
0.322
AC XY:
230974
AN XY:
716884
show subpopulations
African (AFR)
AF:
0.384
AC:
12725
AN:
33174
American (AMR)
AF:
0.579
AC:
24242
AN:
41868
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
8803
AN:
25770
East Asian (EAS)
AF:
0.743
AC:
29038
AN:
39088
South Asian (SAS)
AF:
0.247
AC:
20633
AN:
83584
European-Finnish (FIN)
AF:
0.242
AC:
12746
AN:
52576
Middle Eastern (MID)
AF:
0.258
AC:
1485
AN:
5752
European-Non Finnish (NFE)
AF:
0.308
AC:
339735
AN:
1103186
Other (OTH)
AF:
0.339
AC:
20312
AN:
59850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
15929
31858
47788
63717
79646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11434
22868
34302
45736
57170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.354
AC:
53832
AN:
152126
Hom.:
10187
Cov.:
33
AF XY:
0.354
AC XY:
26341
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.386
AC:
16032
AN:
41482
American (AMR)
AF:
0.471
AC:
7213
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.330
AC:
1147
AN:
3472
East Asian (EAS)
AF:
0.712
AC:
3681
AN:
5170
South Asian (SAS)
AF:
0.254
AC:
1226
AN:
4828
European-Finnish (FIN)
AF:
0.231
AC:
2442
AN:
10576
Middle Eastern (MID)
AF:
0.274
AC:
80
AN:
292
European-Non Finnish (NFE)
AF:
0.308
AC:
20954
AN:
67986
Other (OTH)
AF:
0.378
AC:
799
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1777
3554
5332
7109
8886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.335
Hom.:
37619
Bravo
AF:
0.382
Asia WGS
AF:
0.466
AC:
1616
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 29, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RIN2 syndrome Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
7.0
DANN
Benign
0.47
PhyloP100
-0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2076584; hg19: chr20-19970705; COSMIC: COSV54788376; API